Ellsworth Advisors LLC Has $625,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Ellsworth Advisors LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,228 shares of the healthcare conglomerate’s stock after acquiring an additional 119 shares during the period. Ellsworth Advisors LLC’s holdings in UnitedHealth Group were worth $625,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Norges Bank acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth about $5,802,231,000. Swedbank AB purchased a new stake in UnitedHealth Group in the 1st quarter valued at about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after buying an additional 1,196,758 shares during the last quarter. Jennison Associates LLC increased its stake in UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the last quarter. Finally, California Public Employees Retirement System increased its stake in UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after buying an additional 815,822 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms have commented on UNH. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. UBS Group increased their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Truist Financial increased their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, TD Cowen increased their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Price Performance

Shares of UNH traded down $1.93 during mid-day trading on Friday, reaching $577.68. 2,190,173 shares of the stock traded hands, compared to its average volume of 4,224,914. The firm has a fifty day moving average price of $529.38 and a 200 day moving average price of $507.42. The company has a market cap of $533.44 billion, a price-to-earnings ratio of 35.31, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the business earned $6.14 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.